August 6, 2024

Day

UofL cardiologist Roberto Bolli, center, leads a new, multicenter clinical trial of an IV-delivered stem cell therapy for heart failure at the University of Louisville and UofL Health. UofL photo.
A new stem cell therapy for heart failure is being tested in patients at the University of Louisville and UofL Health. The trial is the first in the U.S. to test umbilical cord-derived stem cells in patients for heart failure and the first to use intravenous (IV) delivery of cell therapy for heart failure. It...
Read More